The Protea Cancerscreen 125 is a
set of more than 125 individual protein samples isolated from tumor
and matched adjacent normal frozen tissue samples, transferred onto a
Nitrocellulose membrane (dotblot). All major cancer types are
represented. The Cancerscreen 125 is intended
for research use, to determine protein expression patterns in specific
stages of cancer, and is provided with demographic and pathology data
for all source samples.